Skip to main content
OpenTrials

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

1,027 public trials 268 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Recruiting

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

NCT03328078

Conditions
Disease Attributes, Hematologic Diseases, Hematologic Neoplasms, +17 more
Locations
  • St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • Providence St. John's Health Center Santa Monica, California, United States
View all 45 locations
View Trial Details
Recruiting

Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial

NCT06510699

Conditions
Bacterial Infections and Mycoses, Blood Cancer, Communicable Diseases, +13 more
Locations
  • Fred Hutchinson Cancer Centre Seattle, Washington, United States
  • Sydney Children's Hospital Network Sydney, New South Wales, Australia
  • Westmead Hospital Sydney, New South Wales, Australia
  • Royal Brisbane & Women's Hospital Brisbane, Queensland, Australia
View Trial Details
Recruiting

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT06001788

Conditions
AML, AML With Mutated NPM1, Acute Leukemia, +14 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Health - Bowyer Oncology Center Los Angeles, California, United States
  • UC Irvine Health Chao Family Comprehensive Cancer Center Orange, California, United States
View all 45 locations
View Trial Details

Related conditions